Article
Standard therapies versus novel therapies in Hodgkin lymphoma.
Immunology letters - 1 Jan 2000
Gallamini A, Di Raimondo F, La Nasa G, Romano A, Borra A, Greco M
Abstract excerpt
The prognostic models in Hodgkin lymphoma (HL) such as the International Prognostic Score (IPS), retrospectively constructed in the last twenty years from different cohorts of patients treated with ABVD or ABVD-equivalent regimens have been shown a limited predictive value on treatment outcome when applied to a prospective cohort of patients. In the turn of millennium a new class of prognostic factors has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.